Management tracks: Trio of female exec appointments; plus FDA, Cell and Gene Therapy Catapult, SutroVax, Lundquist Institute, RedShift, NeoImmuneTech and more

Three women were appointed this week to C-suite positions at biotechs with valuations over $1 billion. The hires come the same week as a report from BIO that found that about 30% of biotech executives are female (see

Read the full 387 word article

How to gain access

Continue reading with a
two-week free trial.